- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06979856
- Original Trial
Short, Animated Storytelling (SAS) Videos to Reduce Smartphone Addiction in the US (SAS)
March 31, 2026 updated by: Maya Adam, Stanford University
Short, Animated Storytelling Videos to Reduce Smartphone Addiction in the US: Protocol for an Online, Randomized Controlled Trial
This study will test the effect of exposure to short, animated storytelling videos on participants' perceived risk of smartphone overuse immediately after exposure, two weeks later and four weeks later.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- English Speaking
- Own a Smartphone
- Live in the US
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Informational Control
Participants will read a fact sheet containing written information and statistics about smartphone usage.
|
A short fact sheet presenting written information and statistics about smartphone usage.
|
|
No Intervention: Do-nothing control
Participants will only complete the surveys.
Participants do not receive any intervention or information about digital addiction.
|
|
|
Experimental: Animated videos
Participants will watch two short, animated storytelling videos about digital addiction.
|
The short animated videos (approximately 2 minutes each) draw attention to the dangers of smartphone addiction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smartphone Addiction Scale (SmAS) score
Time Frame: Baseline, 2 weeks and 4 weeks post intervention
|
SmAS is a short 10 item validated scale measuring smartphone addiction.
The minimum value is 10 and the maximum value is 60 for this scale.
|
Baseline, 2 weeks and 4 weeks post intervention
|
|
Mobile Phone Attachment Scale - Anxious Attachment Sub Scale (MPAS-AA)
Time Frame: Baseline, immediate post-intervention (up to 24 hours), 2 weeks and 4 weeks post intervention
|
The MPAS Anxious Attachment subscale comprises 7 items rated 1 (not at all true) to 5 (extremely true).
Subscale scores were computed as the mean of the 7 items (range 1-5), with higher scores indicating greater anxious attachment to one's mobile phone.
The MPAS-AA has demonstrated good internal consistency (α=.87) and external validity.
|
Baseline, immediate post-intervention (up to 24 hours), 2 weeks and 4 weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mobile Phone Attachment Scale - Addiction Sub Scale (MPAS_Addiction)
Time Frame: Baseline, 2 weeks and 4 weeks post intervention
|
Mobile phone addiction will be assessed with the MPAS Addiction subscale (6 items).
Items are rated on a 5-point scale from 1 = not at all true to 5 = extremely true; responses are averaged to create a subscale score (range 1-5), with higher scores indicating greater addictive/problematic mobile phone use.
|
Baseline, 2 weeks and 4 weeks post intervention
|
|
Perceived Danger of Smartphone Overuse measured using a visual analogue scale (VAS)
Time Frame: Baseline, immediately post intervention exposure (up to 24 hours), 2 weeks and 4 weeks post intervention exposure
|
Perceived danger of smartphone overuse will be assessed with a single-item 10-point slider (visual analogue-type scale) ranging from 0 = not at all dangerous to 10 = extremely dangerous.
Higher scores indicate greater perceived danger.
|
Baseline, immediately post intervention exposure (up to 24 hours), 2 weeks and 4 weeks post intervention exposure
|
|
Self-reported daily smartphone use (past 2 weeks)
Time Frame: Baseline, 2 weeks and 4 weeks post intervention exposure
|
Self-reported daily smartphone use will be assessed via a single self-report item asking participants: 'On average, how many hours per day did you use your phone over the past two weeks?' Responses are recorded in 6 ordered categories: <1 h, 1-2 h, 2-4 h, 4-6 h, 6-8 h, >8 h, with higher categories indicating greater daily use.
|
Baseline, 2 weeks and 4 weeks post intervention exposure
|
|
Self-perceived smartphone addiction (single item; Olsen)
Time Frame: Baseline, immediately post intervention exposure (up to 24 hours) 2 weeks and 4 weeks post intervention exposure
|
Self-perceived smartphone addiction will be assessed using Olsen's single-item smartphone addiction measure, asking agreement with the statement 'I am addicted to my smartphone' on a 6-point Likert scale from Strongly disagree (1) to Strongly agree (6).
Higher scores indicate greater self-perceived smartphone addiction.
|
Baseline, immediately post intervention exposure (up to 24 hours) 2 weeks and 4 weeks post intervention exposure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maya U Adam, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2026
Primary Completion (Actual)
March 26, 2026
Study Completion (Actual)
March 26, 2026
Study Registration Dates
First Submitted
May 6, 2025
First Submitted That Met QC Criteria
May 19, 2025
First Posted (Actual)
May 20, 2025
Study Record Updates
Last Update Posted (Actual)
April 2, 2026
Last Update Submitted That Met QC Criteria
March 31, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 80171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smartphone Addiction
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedSmartphone Users, Smartphone Addiction, Anxiety, and Skin ConductanceTaiwan
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
Beijing Normal UniversityCompleted
-
Mersin UniversityÇankırı Karatekin University; Scientific and Technological Research Council...CompletedInternet Addiction | Smartphone Addiction | Technology AddictionTurkey (Türkiye)
-
Anhui Medical UniversityCompletedSmartphone AddictionChina
-
Istanbul Medeniyet UniversityRecruitingDysfunctional Breathing | Smartphone Addiction | Postural DisordersTurkey (Türkiye)
-
Karabuk UniversityCompleted
-
Kutahya Health Sciences UniversityCompleted
-
Inonu UniversityCompletedSmartphone AddictionsTurkey (Türkiye)
-
Hacettepe UniversityIstinye UniversityCompletedSmartphone Addiction | Postural Instability | Balance AssessmentTurkey (Türkiye)
Clinical Trials on Informational Control
-
Florida International UniversityUniversity of MichiganCompletedHIV/AIDSUnited States
-
University of PennsylvaniaSociety of Family PlanningCompleted
-
Indiana UniversityIndiana Clinical and Translational Sciences InstituteCompletedCOVID19 Behavioral ProphylaxisUnited States
-
Boston University Charles River CampusNational Institute on Drug Abuse (NIDA); Virginia Polytechnic Institute and... and other collaboratorsCompleted
-
University of Texas at AustinNot yet recruitingOsteoarthritis | Lateral Epicondylitis | Rotator Cuff Tendinopathy | Dupuytren Contracture | Carpal Tunnel Syndrome (CTS) | Trigger Digit | De Quervain Disease | Non-traumatic Musculoskeletal ConditionsUnited States
-
VA Office of Research and DevelopmentCompletedStroke | HypertensionUnited States
-
Children's Hospital Medical Center, CincinnatiTerminated
-
University of California, DavisCompletedAttitude | IntentionUnited States
-
University of TennesseeRecruitingChild Development | Prone PositionUnited States